Safety and Efficacy of Switching Injected Peptide Long-Acting Somatostatin Receptor Ligands to Once Daily Oral Paltusotine: ACROBAT Edge Phase 2 Study

Authors
Category Primary study
JournalJournal of the Endocrine Society
Year 2021
This article has no abstract
Epistemonikos ID: 85faaffb33ecc3e8c421d2045cee5a0f16da032a
First added on: Jun 13, 2024